The Health Technology Board for Scotland provides timely advice on the clinical and cost effectiveness of the broad range of existing and new health technologies to NHSScotland, including most recently for mental health on:the prescription of anti-cholinesterases to people with Alzheimer's Disease, andthe prescription of atypical anti-psychotics to people with schizophrenia.NHS Scotland and their care partners will also continue to invest in treatments, approaches, services, support and other interventions that aim not only to treat but also to prevent or reduce the incidence and individual severity of mental illness in Scotland.